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Abstract
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported
from countries between 30uN and 15uS since 1840 but the exact burden of disease is not known. It is currently unknown
what the incidence, prevalence and the number of reported cases per year per country is. In order to estimate what the
global burden of mycetoma is, a meta-analysis was performed. In total 50 studies were included, which resulted in a total of
8763 mycetoma cases. Most cases were found in men between 11 and 40 years of age. The foot was most commonly
affected. Most cases were reported from Mexico, Sudan and India. Madurella mycetomatis was the most prevalent causative
agent world-wide, followed by Actinomadura madurae, Streptomyces somaliensis, Actinomadura pelletieri, Nocardia
brasiliensis and Nocardia asteroides. Although this study represents a first indication of the global burden on mycetoma, the
actual burden is probably much higher. In this study only cases reported to literature could be used and most of these cases
were found by searching archives from a single hospital in a single city of that country. By erecting (inter)national
surveillance programs a more accurate estimation of the global burden on mycetoma can be obtained.
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Introduction
Mycetoma is a chronic infectious disease, characterized by the
formation of tumor like-swellings and the formation of grains. This
disease usually begins with a small trauma on the foot which
introduces the causative agent into the subcutaneous tissue. Inside
this tissue the causative agent will organize itself into small
granules called grains. A small nodule will arise which gradually
will grow into a large subcutaneous mass with sinuses which will
secrete pus and grains. Eventually the bone will be invaded and a
large mutilating lesion will be formed and the foot will be
amputated [1]. Although mycetoma is usually found in the foot,
other body sides can be affected as well [2].
Although, the first documented clinical cases of mycetoma
were already described in 1842 by Gill, uncertainty remains
about the total number of cases world-wide as already
mentioned by Gokhale in 1981 [3]. A first attempt to map
the number of mycetoma cases in a certain region was made by
Abbott in the early 1950s [4]. Abbott, studied 1321 mycetoma
cases in the Sudan in a 2.5 year period and published his
findings in 1956 [4]. Many scientists were surprised by the
amount of cases to be retrieved in such a small period, which
could indicate that the burden of mycetoma was higher than
previously thought. Therefore, others started to determine the
burden of mycetoma in other countries known to be endemic
for mycetoma, such as Congo [5], Somalia [6,7,8,9], Argentina
[10,11] and Mexico [12,13]. Although several studies have been
performed to determine the prevalence of mycetoma in a
certain region or country, no overall study has been performed
to determine the prevalence of mycetoma world-wide. Further-
more mycetoma is not a reportable disease; therefore it is
currently still not known what the global burden of mycetoma
is.
In the surveys performed in the past and based on case-studies it
appeared many different species, both bacteria and fungi, are able
to cause mycetoma. In the review written by Ahmed et al. 48
species were listed as causative agents [1]. Some of these agents
were considered to be common causative agents of mycetoma
while others were found only rarely. A definition on common or
rare was not given. Recently, based on sequencing either the 16S
region (for bacteria) or the ITS region (for fungi) more causative
agents were added to this list [14,15,16]. Since molecular
identification is not used in the endemic regions, the total number
of species able to cause mycetoma is still not known. Furthermore,
no clear definition is given which species are common causative
agents of human mycetoma and which are only rarely implicated.
The distribution of the mycetoma causative agents is not equal
around the globe. In overall, actinomycetoma – mycetoma caused
by bacteria – is more commonly found in Middle and South-
America while eumycetoma – mycetoma caused by fungi – is more
commonly found in Africa [4,13]. But within a country, this could
also differ per region [17,18].
In order to estimate what the true burden of mycetoma is
globally, a meta-analysis was performed in which all studies in
which the epidemiology of the mycetoma causative agents was
studied were reviewed. Studies with more than 10 cases were
included. The burden of mycetoma was determined in terms of
prevalence and the number of reported cases per year per country.
Furthermore we determined which species were most commonly
associated with mycetoma and prepared definitions based on the
,8000 cases to determine which species were commonly,
occasionally or rarely associated with mycetoma development.
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Methods
Search strategy
A systematic review of available literature on the epidemiology
of mycetoma was searched using the electronic database PubMed
with the use of the following search terms: Mycetoma AND
epidemiology or Madura foot AND epidemiology. Studies
published in languages other than English, French, Spanish,
Portuguese, German or Dutch were excluded. The search was
supplemented by reviewing the reference lists of all selected
studies. Studies were excluded if the number of patients studied
was ,10 patients, if a study was already published before and if
the paper was written as a review.
Prevalence
To determine the prevalence for each country, the number of
reported cases for each year for that country were divided through
the total population of that country for that year. Population
figures were derived from IndexMundi (http://www.indexmundi.
com/facts/indicators/SP.POP.TOTL/compare#country = ma).
This site only gives data from 1960 onwards. If studies had data
from older years, the population size of 1960 was used to calculate
the prevalence. To determine the prevalence within individual
Indian states, population figures were derived from http://www.
citypopulation.de/India.html.
Calculations and definitions to determine prevalent
species
From each study, the sampling period, the region of sampling, the
sex distribution, age distribution and species isolated were recorded.
To determine which species were most prevalent the percentages of
each species present in a certain study was calculated. The percentage
was used for comparison since some studies reported on.2000 cases
while others reported only 11. To determine the global prevalence,
the sum of the means for each country for a certain species was taken
and then divided by the total of countries included. To determine
which species were most prevalent the following definitions were
used: common:.5% of the reported cases world-wide was caused by
this species; occasional: 1–5% of the reported cases world-wide was
caused by this species; rare: ,1% of the reported cases world-wide
was caused by this species.
Author Summary
Mycetoma is a chronic infection resulting in large masses
of the subcutaneous tissue of mainly the foot. It can be
caused by bacteria or fungi. Treatment for most mycetoma
cases is poor and amputations are common. Although this
disease was already described almost 200 years ago, it is
currently not known how many people over the globe
actually suffer from this disease and which countries are
mostly affected. These data are useful because they can be
used to concentrate medical help in places where it is
really needed and to focus to search on new medication
on the most common causative agents. Since mycetoma is
not a reportable disease, a meta-analysis was performed
based from reports in literature, in order to estimate what
the global burden of mycetoma is. In total 8763 mycetoma
cases were analysed. It appeared that most cases were
reported from Mexico, Sudan and India and that the
fungus Madurella mycetomatis was the most prevalent
causative agent world-wide. Although this study repre-
sents a first indication of the global burden on mycetoma,
the actual burden is probably much higher. By erecting
(inter)national surveillance programs a more accurate
estimation of the global burden on mycetoma can be
obtained.
Figure 1. Flow diagram of literature search. In this flow diagram it is shown that 258 titles and abstracts were screened initially. 50 papers were
screened of which 17 were excluded due to failing the inclusion criteria, studies reported in two different studies, being reviews and 1 could not be
retrieved. After manually searching the references of each of the retrieved papers, 17 more papers were identified and included in the analysis. This
resulted in a total of 50 papers analysed.
doi:10.1371/journal.pntd.0002550.g001
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Results
Our systematic review identified 258 studies of which 49 full
articles were reviewed (Figure 1). Via manually searching of the
references used in those studies an additional 17 studies were
included. In total 17 studies were excluded for analysis because
they did not meet the inclusion criteria (5 studies) [11,
19,20,21,22], or contained data already published in another
paper (6 studies) [8,23,24,25,26,27] or consisted of reviews instead
of original data (5 studies) [3,5,28,29,30] or could not be retrieved
(1 study). This led to a total number of 50 studies to be included
into the study [4,6,7,9,10,12,13,17,18,31,32,33,34,35,36,37,38,39,
40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,
61,62,63,64,65,66,67,68,69,70,71]. From each of these studies the
number of cases was recorded, the gender of the patients, age of
the patients, site of the lesion and the causative agents isolated.
Figure 2. Prevalence and the number of reported cases of mycetoma. A: Average prevalence of mycetoma cases as calculated by the
number of cases reported in a year in a certain country divided trough the total population of that country of that same year as reported by www.
indexmundi.com/facts/indicators/SP.POP.TOTL/compare. B: the average number of mycetoma cases reported per year per country.
doi:10.1371/journal.pntd.0002550.g002
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World-wide distribution of mycetoma
In total 8763 mycetoma cases were included in this study. Most
of the cases were reported from Mexico (2607 cases) [12,13,53],
Sudan (2555 cases) [4,34,70] and India (1392 cases) [17,18,
35,42,44,51,59,60,65,66,67]. Countries with only limited cases
reported are Uganda (11 cases) [64], Rumania (13 cases) [68],
Nigeria (15 cases) [55], Bulgaria (16 cases) [58] and Thailand (17
cases) [56].
In order to estimate the prevalence of mycetoma the number of
reported cases for each year for that country were divided through
the total population of that country for that year as shown in
figure 2A. As you can see in this figure, countries with the highest
prevalence include Mauritania (prevalence of 3.49 cases per
100,000 inhabitants) and Sudan (prevalence of 1.81 cases per
100,000 inhabitants). Also Mexico, Senegal, Niger and Somalia
have a relatively high prevalence for mycetoma. In order estimate
the number of mycetoma cases reported per year the following
calculation was made: the total number of cases was divided
through the number of years in which they were gathered
(figure 2B). So if we take as an example Mali. In Mali 54 cases
were reported in a 10 year period between 1985 and 1994 [45]. So
in total there were 54/10 = 5.4 cases/year seen. According to
figure 2B, Sudan reported the highest number of cases yearly,
namely 106 per year. For Mexico and Mauritania, this was 80.7
and 69.7 respectively.
Mycetoma is commonly found in the foot of man
World-wide most cases were found in men: 4060 cases in men
versus 1175 cases in women. Exceptions were Thailand and
Tunisia. In Thailand, men and women were equally affected (8
man and 9 women), while in Tunisia actually mycetoma was
reported more in women (16 cases) than in men (12 cases). As is
seen in figure 3, of the 5240 cases in which age was reported, 70%
of the cases (3664 cases) were found in people with an age between
11 and 40 (3664 cases). Furthermore the most affected body site
was the foot (68.7%), followed by the leg (9.9%), trunk (6.1%) and
arm (4.0%) (Figure 4). Although these observations were based on
all the cases reported world-wide, there are some regional
differences. In all studies, the foot was the most reported lesion
site, but in South-American patients the trunk was more often the
site of infection than in African or Asian patients. For example, in
Sudan the trunk as lesion site was only reported in 1.4% of the
cases, while in Mexico it was reported in 18.7% of all cases.
The most common causative agents
As is seen in table 1, most cases were actinomycetoma cases, but
the total number of actinomycetes able to cause mycetoma is less.
In total, 7 different actinomycetes were identified in the studied
actinomycetoma cases, but for some cases the causative agents was
not identified to the species level. Some were classified as Nocardia
spp. and others as actinomycetoma spp. Based on our criteria the
species Actinomadura madurae, Streptomyces somaliensis, Actinomadura
pelletieri, Nocardia brasiliensis and Nocardia asteroides were considered to
be common causative agents. Each of them was found in .5% of
the studied cases. Nocardia otidiscaviarum was only found occasion-
ally, and Actinomyces israeli rarely.
For the eumycetoma cases, 18 different fungal species were
identified as causative agents. Furthermore, for some cases the
fungus could not be identified to the species level, but only to the
genus level. These belonged to the genera Fusarium, Cladosporium or
Exophiala. For 219 fungi, the fungus was not even identified to the
genus level. Only the fungus Madurella mycetomatis was considered
to be a common causative agent. In fact it appeared the most
common causative agent of all mycetoma cases since 24.3% of all
studied cases were caused by this fungus. Scedosporium boydii,
Falciformispora senegalensis and Trematosphaeria grisea were occasionally
isolated from mycetoma cases, and Acremonium falciforme, Aspergillus
fumigatus, Exophiala jeanselmei, Geotrichum candidum, Neotestudina rosatii,
Figure 3. Age distribution of the mycetoma patients. Age distribution as reported in 5240 cases of mycetoma. For the other 3523 cases no
detailed information was available.
doi:10.1371/journal.pntd.0002550.g003
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Medicopsis romeroi, Biatriospora mackinnonii, Aspergillus flavus, Microspo-
rum audouini, Cochliobolus lunatus, Rhinocladiella atrovirens, Aspergillus
nidulans and Neoscytalidium dimidiatum only rarely.
The identified species were not evenly distributed throughout
the world (Figure 5). M. mycetomatis, S. somaliensis and A. pelletieri
were highly prevalent in Africa and Asia but hardly found in
South-America. In contrast, the most prevalent species encoun-
tered in South America, N. brasiliensis, was hardly found in Africa,
Europe and Asia. The only species which was found on all
continents in equal amount was A. madurae.
India, as example
Until now, we generalized all studies per country, but within a
country there can be large differences. As an example India is
taken, since from this country we had data from 11 different
studies. These studies originated from different parts of the
country, namely Punjab, Rajasthan, Madhya Pradesh, Adhra
Pradesh, Tamil Nadu and West-Bengal. Most of these states have
roughly the same population size at the time most studies were
performed (,50,000,000 inhabitants/state in 1981), only Punjab
had a smaller population (16,788,915 inhabitants/state in 1981).
As is seen in figure 6, in Rajasthan most cases were reported per
year (33.3), followed by Tamil Nadu (16.8 reported cases/year)
and West-Bengal (13.2 reported cases/year). The reported species
per state also differed, in Rajasthan 62.5% of all mycetoma cases
was caused by fungi, while in the other states most cases were
caused by actinomycetoma’s (54.3%–83.3% of all mycetoma
cases). Not surprisingly, the species encountered also differed per
state (figure 6).
Discussion
Since it is currently not known what the global burden of
mycetoma is in terms of prevalence and incidence, we tried to
Figure 4. Mycetoma lesion site. The mycetoma lesion site. In this figure the percentage of cases reported from a certain body site is shown. For
2.6% of the cases the lesion site was unknown to the authors and 1.0% of the patients had multiple lesions. The percentages shown in this figure
were calculated from data obtained from 4581 cases. For the other 4182 cases no detailed information was available.
doi:10.1371/journal.pntd.0002550.g004
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make a rough estimation by performing a meta-analysis on the
published literature from 1955 onwards. The number of papers
published around the globe was relatively little. Only 50 papers
could be used, which resulted in a total number of 8763 mycetoma
cases documented since 1944. The globally reported number of
cases is therefore 127 cases/year. The 8763 mycetoma cases were
reported from 23 different countries. For some countries we only
had data on 11 cases (e.g. Uganda), while for others we had data
on 2607 cases (Mexico). The more cases reported per country the
more reliable the data are. Since for most studies we knew in
which years the cases were seen, a rough prevalence figure was
calculated by dividing the number of cases seen in each year
through the total population of that country in that year. This
resulted in prevalence numbers ranging from ,0.01 cases per
100,000 inhabitants (several countries) to 1.8 cases per 100,000
inhabitants (Sudan) and an average of cases reported per year
ranging from 0.9 (Tunesia) to 106 (Sudan) (Figures 2A and 2B).
These numbers are gross underestimations of the true prevalence,
since only cases reported to literature could be used. Most of these
cases were found by searching archives from a single hospital in a
single city of that country. Only those studies which searched
multiple centres throughout the country, such as the studies
performed by Abbott in Sudan [4] and by Lopez Martinez in
Mexico [13], more than 1000 patients were documented. Based
on these short-comings we estimate that the total number of
mycetoma cases will be much higher.
Some evidence of a higher prevalence exists, although not
reported to literature. For instance, in 1991 the Mycetoma
Table 1. Number of species identified by selected papers.
Species
Colour of the
grain*
Number of
isolates Percentage Prevalence**
Actinomycetoma 4832 50.84
Actinomadura madurae W/Y/P 594 10.21 C
Streptomyces somaliensis Y/Br 677 10.16 C
Actinomadura pelletieri R 594 6.71 C
Nocardia brasiliensis W 1946 5.78 C
Nocardia asteroides W 108 5.58 C
Nocardia otidiscaviarum (synonym: Nocardia caviae) W/Y 51 1.08 O
Actinomyces israeli W/Y 1 0.07 R
Nocardia spp W/Y 371 4.64
Unidentified actinomycetes 590 6.60
Eumycetoma 2704 41.72
Madurella mycetomatis B 2032 26.44 C
Scedosporium boydii (synonym: Scedosporium apiospermum or Pseudallescheria boydii) W 83 3.52 O
Falciformispora senegalensis (synonym: Leptosphaeria senegalensis) B 167 2.01 O
Trematosphaeria grisea (synonym: Madurella grisea) B 116 1.62 O
Acremonium falciforme (synonym: Cephalosporium falciforme) W 3 0.73 R
Aspergillus fumigatus 2 0.40 R
Exophiala jeanselmei B 9 0.37 R
Geotrichum candidum 1 0.33 R
Neotestudina rosatii W 4 0.33 R
Medicopsis romeroi B 22 0.26 R
Medicopsis romeroi or Biatriospora mackinnonii (synonym: Pyrenochaeta spp) B 7 0.21 R
Aspergillus flavus G 2 0.07 R
Microsporum audouini W 1 0.04 R
Cochliobolus lunatus (synonym: Curvularia lunata) B 2 0.01 R
Rhinocladiella atrovirens 2 0.01 R
Aspergillus nidulans W 1 0.003 R
Neoscytalidium dimidiatum 1 0.003 R
Fusarium spp W 13 0.34
Cladosporium spp 1 0.14
Exophiala spp B 2 0.006
Unidentified fungi 220 4.72
Unknown etiology 217 7.49
TOTAL 7753 100
*colour of the grain: black (B), brown (Br), green (G), pink (P), red (R), white (W), yellow (Y).
**prevalence: common (C): species isolated .5%; occasional (O): species isolated 1–5%; rare species isolated ,1%.
doi:10.1371/journal.pntd.0002550.t001
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Research Centre in Khartoum, Sudan was established. Since its
founding, 6334 patients have been seen. In 2012 only, 5158
patients were seen of which 402 were new cases. This means that
there were (5158 cases/year) seen in Sudan only, which were not
reported to literature (prof A. Fahal, personal communication).
Furthermore, the incidence calculated on the figures from the
Mycetoma Research Centre are most probably also an underes-
timation, since a cohort study performed in the endemic village
Abu Gumri in Sudan performed in 1960, indicated that there was
a prevalence of 6.2 per 1000 inhabitants in that particular village
[72].
Although the reported number of cases seen per year in this
study is an underestimation, they are comparable with the number
of cases reported for Buruli Ulcer and human African trypano-
somiasis in many countries [73]. For instance, the number of
reported Buruli Ulcer cases in 2009 were below 100 cases for
Australia, Sudan, Gabon, Nigeria, and Guinea, while there were
between 100 and 500 cases reported in Cameroon, Congo and the
Democratic republic for the Congo in that year [73]. The number
of reported Human African Trypanosomiasis (HAT) from
surveillance studies in 2009 were below 100 reported cases for
Kenya, Tanzania, Malawi, Zambia, Zimbabwe, Congo, Camer-
oon and Gabon [74]. The countries in which between 100 and
500 HAT cases were reported included Sudan, Angola and
Uganda [74]. The data obtained for both Buruli Ulcer and HAT
were from surveillance data, which makes these numbers more
reliable than, the number of mycetoma cases/year reported here
were derived from single center studies, and represent an
underestimation. Therefore the prevalence of mycetoma is
probably higher than that of either Buruli Ulcer or HAT. Still,
Buruli Ulcer and HAT are reported on the list of neglected
diseases while mycetoma is not.
In this study it was shown that mycetoma could be caused by
many different micro-organisms, both bacteria and fungi. Glob-
ally, most cases were caused by bacteria (50.8%) and a smaller
percentage by fungi (41.7%) (Table 1), although this differed per
country. In many African countries actually more eumycetoma
cases were found as actinomycetoma cases. In table 1 it was also
shown that there are many different bacteria and fungi able to
cause mycetoma. There were 7 different bacterial species and 16
different fungal species reported. The total list of species able to
cause mycetoma is actually longer. Since we only focused on
studies reporting more than 10 cases per study, we missed the
many species named in case reports. Other bacterial species
implicated in mycetoma are Actinomadura latina, Gordonia terrae,
Nocardia farcinica, Nocardia harenae, Nocardia mexicana, Nocardia
transvalensis, Nocardia veterana, Nocardia yamanashiensis, Nocardiopsis
dassonvillei and Streptomyces sudanensis [1,14,75,76,77,78,79,80,
81,82,83]. Other fungal species implicated in mycetoma are
Acremonium recifei, Cladophialophora bantiana, Corynespora cassiicola,
Curvularia geniculata, Diaporthe phaseolorum, Fusarium oxysporum, Gibberella
fujikuroi (synonym: Fusarium monoliforme), Haematonectria haematococca
Figure 5. Distribution of the most common causative agents per country. The distribution of Madurella mycetomatis, Actinomadura
madurae, Streptomyces somaliensis, Actinomadura pelletieril, Nocardia brasiliensis and Nocardia asteroids per country. For each country the number (N)
of species identified is given. The percentage of Madurella mycetomatis, Actinomadura madurae, Streptomyces somaliensis, Actinomadura pelletieril,
Nocardia brasiliensis and Nocardia asteroids were calculated from these data and displayed in the corresponding panels.
doi:10.1371/journal.pntd.0002550.g005
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(synonym: Fusarium solani), Ilyonectria destructans (synonym: Cylindro-
carpon destructans), Falciformispora tompkinsii (synonym: Leptosphaeria
tompkinsii), Madurella fahalii, Madurella pseudomycetomatis, Madurella
tropicana, Microsporum canis, Phaeoacremonium parasiticum, Phialophora
cyanescens (synonym: Cylindrocarpon cyanescens), Phialophora verrucosa,
Pleurostomophora ochracea, Pseudochaetosphaeronema larense, Rhinocladiella
atrovirens, Sarocladium kiliense (synonym: Acremonium kiliense), Setosphaeria
rostrata (synonym: Exserohilum rostrata) [1,15,
16,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98]. Since most of
these species are only found in case studies, these are probably only
rarely associated with mycetoma, if associated at all.
Although most species represented in Table 1 were isolated
from multiple cases, some species were only isolated from 1–5
cases, which makes one wonder if this was the true causative agent.
Only for Nocardia asteroides [99], Nocardia brasiliensis [99,100,
101,102], Nocardia caviae [99,100], Nocardia transvalensis [103],
Madurella mycetomatis [104,105] the pathogenicity in animal models
has been demonstrated. In all these animal models pathology
resembling mycetoma and the formation of grains was demon-
strated. The only attempt ever recorded for Actinomadura madurae,
Actinomadura pelletieri and Streptomyces somalienis failed [104]. So, one
could wonder if all species listed in Table 1 and in the discussion
are true causative agents for mycetoma.
The causative agents presented in Table 1 were identified based
on histology only or on histology combined with culture. Therefore,
the possibility arises that some of the causative agents were
misidentified. Although widely used, the limitations of histological
diagnosis have been known since the early 1960s. It is impossible to
differentiate Nocardia spp. to the species level based on histology
only, all species form white to yellow, small spherical grains
[106,107]. Also S. boydii, Acremonium spp and Fusarium spp are
difficult to differentiate [106,107]. These species produce white to
yellow grains with a dense mass of slender, septate, hyaline hyphae
with occasional vesicles or swollen hyphae [107]. The black-grain
causative agents F. senegalensis, F. tompkinsii, M. romeroi, Exophiala
jeanselmei and T. grisea also produce similar type of grains [107].
These species produce black grains, which can be tubular or hollow
with a darker periphery [107]. The Falciformispora grains usually
contain larger vesicles than the other species [107]. Some causative
agents can cause multiple grain types in histological slides. Madurella
mycetomatis is known to produce three structural forms of the fungal
grain: the filamentous type, the vesicular type and a mixture of both
[2]. In the vesicular type of grain the center is light colored and the
hyphae in the periphery are brown, just as the ones described above
for F. senegalensis, F. tompkinsii, M. romeroi, Exophiala jeanselmei and T.
grisea [2]. For some of the studies culturing of the causative agents
was also included. But identification of species based on culturing
only, has known to be troublesome too, especially for the fungi.
Identification of the fungi is usually achieved by observation of the
growth rate, colony morphology, production of conidia and
assimilation patterns. Most of the black-grain eumycetoma
causative agents only rarely produce conidia and therefore
Figure 6. India. Average number of mycetoma cases reported per year in India per state and the causative agents per state.
doi:10.1371/journal.pntd.0002550.g006
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misidentifications are known to occur frequently [108]. A well-
known example is T. grisea, previously known as Madurella grisea.
Due to the numerous misidentifications McGinnis suggested in
1996 that this species should be considered a complex of different
fungi, classified together because of their sclerotial color and
architecture and colony characteristics [109]. Some isolates of B.
mackinnonii are known to be misidentified as T. grisea, since some of
these isolates did not form pycnidia at standard media, but only
after stimulation [109]. Furthermore, with classical culture
methods, not all species can be differentiated. An example is
Streptomyces sudanensis, which morphologically is equal to Streptomyces
somaliensis. Only by sequencing the 16S gene of these species, it
appeared that out of 9 previously identified S. somaliensis strains, 5
were actually misidentified and were renamed S. sudanensis [14].
The same was true for M. mycetomatis, in 2012 it appeared that M.
mycetomatis had some close relatives which could only be identified
by ITS sequencing, not on morphology [15]. Even when the species
was already known, misidentifications have occurred in the past. N.
brasiliensis has always been considered the most common causative
agent of actinomycetoma in Mexico. Sa´nchez-Herrara demon-
strated in 2012, that from the 18 previously identified N. brasiliensis
isolates obtained from mycetoma patients in Mexico City between
1947 and 1959, only 7 were N. brasiliensis, the other 11 were proven
to be N. farcinica based on sequencing and phenotypic profiles [110].
Therefore it remains doubtful that the data derived from the studies
used for this meta-analysis were based on correctly identified
species.
Even with all these short-comings listed of this meta-analysis, it
still gives a good overview of our current knowledge on the burden
of mycetoma world-wide. In order to better estimate the burden,
global surveillance programs should be erected, like for instance
the surveillance program for Buruli Ulcer. This program is the
result of the Global Buruli Ulcer initiative established in 1998 by
the WHO and recognized by the 57th World Health Assembly in
2004 [111]. For this surveillance program, standardized forms
(BU02) were generated which are now used in the endemic
countries. If such a system was developed for mycetoma, better
understanding on the global burden, and the epidemiology of this
disease will be gained.
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